This funding follows Semarion's 2.89 million USD seed round raised in 2022. The lead investor name is missing in the provided content.
About Semarion
Semarion is a University of Cambridge spin-out integrating materials engineering and cell biology to improve drug discovery workflows. Its SemaCyte microcarrier platform converts adherent cells into barcoded, assay-ready microcarriers, enabling higher-throughput and more reproducible cell-based assays.
Cambridge, United Kingdom
Read Company ProfileFrequently Asked Questions
How much did Semarion raise in its ?
Semarion raised $3,800,000 USD in its .
Who invested in Semarion's ?
The investors in Semarion's are: Unspecified Lead Investor, The FSE Group, Cambridge Enterprise Ventures, Oxford Innovation Finance, Found Capital, Cambridge Capital Group, Start Codon.
How will Semarion use the funds from its ?
Semarion plans to use the funds for: scale manufacturing of the SemaCyte platform, advance commercial expansion, strengthen field application support, facilitate broader adoption among pharmaceutical and life sciences partners.